Michael F. DeMane - 12 Apr 2023 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
12 Apr 2023
Net transactions value
+$1,445,238
Form type
4
Filing time
14 Apr 2023, 16:22:11 UTC
Previous filing
04 Apr 2023
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Options Exercise $1,445,238 +80,291 +387% $18.00 101,018 12 Apr 2023 Direct F1
holding NVRO Common Stock 164,344 12 Apr 2023 See footnote F2
holding NVRO Common Stock 82,541 12 Apr 2023 See footnote F3
holding NVRO Common Stock 91,225 12 Apr 2023 See footnote F4
holding NVRO Common Stock 18,266 12 Apr 2023 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVRO Stock Option (Right to Buy) Options Exercise $0 -80,291 -100% $0.000000* 0 12 Apr 2023 Common Stock 80,291 $18.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,155 restricted stock units.
F2 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F4 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F5 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
F6 The shares subject to the option are fully vested and exercisable.